Saniona received approximately USD $2.9 million (SEK 24.2 million) upfront payment in connection with Cadent Therapeutics transaction
PRESS RELEASE
January 25, 2021
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it received approximately USD $2.9 million (SEK 24.2 million) in an upfront payment resulting from the now completed acquisition of Cadent Therapeutics by a third party. Saniona holds an ownership stake of approximately 3% in Cadent Therapeutics resulting from Cadent’s previous acquisition of the Saniona spin-out Ataxion, which was created to leverage Saniona’s ion channel expertise for the treatment of movement disorders. Saniona previously announced the planned acquisition and its ownership stake in December 2020.
“Saniona has developed a robust, proprietary drug discovery engine focused on ion channels, a rare scientifically validated drug class that remains significantly untapped,” said Jørgen Drejer, Chief Scientific Officer of Saniona. “It is gratifying to see our ion channel programs create value, and the funding that Saniona received from the Cadent transaction will be beneficial as we continue to advance our own, internal programs for the treatment of rare diseases.”
Following the closing of the acquisition of Cadent Therapeutics by Novartis, Saniona received an upfront payment of approximately USD $2.9 million (SEK 24.2 million), after giving effect to preferred stock preferences and the satisfaction of transaction costs and other closing conditions. Saniona may receive additional contingent consideration upon the achievement of future milestones. In connection with Saniona’s license agreement with Cadent, Saniona is also entitled to receive royalties on any potential products developed and commercialized from the SK ion channel (small conductance, calcium-activated potassium ion channel) program that originated with Ataxion, including CAD-1883, a first-in-class selective positive allosteric modulator of SK ion channels that Cadent has advanced into Phase 2 clinical trials and which may have potential in movement disorders.
Saniona has been a pioneer in the field of ion channels since its founding in 2011, and several members of the Saniona scientific team have been working in this field for more than 20 years. Since its inception, Saniona has out-licensed or spun-out multiple ion channel programs. Ataxion was established in 2013 by Saniona and Atlas Venture Inc. with the aim of developing Saniona's research on SK ion channels for movement disorders. In 2017, Ataxion was acquired by Luc Therapeutics, which later changed its name to Cadent Therapeutics.
For more information, please contact
Trista Morrison, Chief Communications Officer, Saniona. Office: + 1 (781) 810-9227. Email: trista.morrison@saniona.com
The information was submitted for publication, through the agency of the contact person set out above, at 14:00 CET on January 25, 2021.
About Saniona
Saniona is a biopharmaceutical company focused on discovering, developing and delivering innovative treatments for rare disease patients around the world. The company’s lead product candidate, Tesomet, is in mid-stage clinical trials for the rare diseases Prader-Willi syndrome and hypothalamic obesity. Saniona also has a broad pipeline derived from its proprietary ion channel discovery platform, with lead candidate SAN711 entering Phase 1 studies for rare neuropathic disorders. Saniona intends to develop and commercialize its rare disease products internally. The company has out-licensed other programs, which may provide future supplemental revenue. Saniona is based in Copenhagen, Denmark and Boston, Mass., U.S. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Prosafe SE: Operational Update - March 202419.3.2024 13:27:59 CET | Press release
Fleet utilization for February 2024 was 55.9 percent. Safe Notos, Safe Zephyrus and Safe Concordia had utilization of 100 percent in February. Safe Eurus had utilization of 91.3 percent in February due to a repair that was completed during the month. Safe Caledonia is laid up at Scapa Flow in the UK pending future work. Safe Boreas and Safe Scandinavia are laid up in Norway pending future work Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to https://www.prosafe.com Stavanger, 19 March 2024 Prosafe SE For further information, please contact: Terje Askvig, CEO Phone: +47 952 03 886 Reese McNeel, CFO Phone: +47 415 08 186 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Inside Information: Manu Skyttä, new President and CEO of Aspocomp Group Plc, will assume his duties on May 20, 202419.3.2024 13:25:00 CET | Press release
Aspocomp Group Plc, Inside Information, March 19, 2024 at 2:25 p.m. “We are pleased that Manu Skyttä will take up his position as President and CEO of Aspocomp in May. With his character, competence and energy, Mr. Skyttä strengthens Aspocomp’s strategy as a trusted supplier of demanding circuit board technology to all Aspocomp customers. At this point, I would like to thank Mikko Montonen on behalf of the entire Board for his long-term commitment to Aspocomp,” says Päivi Marttila, Chair of Aspocomp’s Board. Manu Skyttä succeeds Mikko Montonen, who, as previously announced, has agreed with the Board of Directors to step down from the role of President and CEO of the company. Mr. Montonen has committed to staying on as the company's President and CEO until May 20, 2024. For further information, please contact Päivi Marttila, the Chair of the Board of Directors, tel. +358 40 028 5358. ASPOCOMP GROUP PLC Board of Directors Aspocomp – heart of your technology A printed circuit board (PCB)
Investeringsforvaltningsaftale med BI Management A/S er godkendt af Finanstilsynet19.3.2024 13:15:48 CET | pressemeddelelse
PFA Asset Management A/S offentliggjorde i selskabsmeddelelse af 22. januar 2024, at Investeringsforeningen PFA Invests (”Foreningen”) bestyrelse havde besluttet at udpege BI Management A/S som investeringsforvaltningsselskab for Foreningen. Finanstilsynet har godkendt valget af BI Management A/S som nyt investeringsforvaltningsselskab for Foreningen. BI Management A/S vil overtage rollen som investeringsforvaltningsselskab seneste ved udgangen af andet kvartal 2024. Eventuel henvendelse vedrørende denne meddelelse kan rettes til direktør Rasmus Bessing. Med venlig hilsen PFA Asset Management A/S Rasmus Bessing Direktør
Offentliggørelse af bestyrelsens redegørelse19.3.2024 13:05:00 CET | pressemeddelelse
Selskabsmeddelelse nr. 8-2023/24 19. marts 2024 MÅ IKKE OFFENTLIGGØRES, PUBLICERES ELLER UDLEVERES DIREKTE ELLER INDIREKTE I ELLER TIL NOGEN JURISDIKTION, HVOR DETTE VILLE UDGØRE EN OVERTRÆDELSE AF GÆLDENDE LOVGIVNING ELLER REGLER I DEN PÅGÆLDENDE JURISDIKTION, HERUNDER I USA Offentliggørelse af bestyrelsens redegørelse Med henvisning til InterMail A/S' ("InterMail") meddelelse af 5. marts 2024 (nr. 7-2023/24) om offentliggørelse af tilbudsdokumentet vedrørende det frivillige offentlige overtagelsestilbud på InterMail fremsat af CapHold 4 inv ApS ("Tilbuddet"), offentliggør InterMail i dag bestyrelsens redegørelse om Tilbuddet ("Redegørelsen") i henhold til § 22 i bekendtgørelse nr. 636/2020 om overtagelsestilbud. Redegørelsen indeholder bestyrelsens holdning til tilbuddet og begrundelsen herfor, herunder bestyrelsens holdning til konsekvenserne for alle selskabets interessenter og til tilbudsgivers strategiske planer for målselskabet samt disses sandsynlige konsekvenser for beskæftige
Zoom Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 202419.3.2024 13:04:05 CET | Press release
SAN JOSE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Zoom Video Communications, Inc. (NASDAQ: ZM), has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2024. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations. These organizations are setting new standards and achieving remarkable milestones in all sectors of the economy. Alongside the World's 50 Most Innovative Companies, Fast Company recognizes 606 organizations across 58 sectors and regions. “At Zoom, we continue to innovate rapidly and are doubling down on our commitment to offering an AI-powered collaboration platform that delivers limitless human connection, reimagines teamwork, and strengthens customer connections,” said Smita Hashim, chief product officer at Zoom. “Fast Company’s recognition further validates our mission and dedication to providing our customers with choice and a high-quality, open collaboration platform power